1 |
EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5. Saha A, Bamidele A, Murakami M, Robertson E.S. |
2 |
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of surviving. Lu J, Murakami M, Verma SC, Cai Q, Haldar S, Kaul R, Wasik MA, Middeldorp J, Robertson E.S. |
3 |
Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. Cai Q., Robertson E.S. |
4 |
Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. Cai Q., Verma S.C., Choi J.Y., Ma M, Robertson E.S. |
5 |
Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. Xiao B, Verma SC, Cai Q, Kaul R, Lu J, Saha A, Robertson E.S. |
6 |
Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Choudhuri T, Murakami M, Kaul R, Sahu SK, Mohanty S, Verma SC, Kumar P, Robertson E.S. |
7 |
Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, Stairs DB, Kalabis J, Vega ME, Kalman RA, Nakagawa M, Klein-Szanto AJ, Herlyn M, Diehl JA, Rustgi AK, Nakagawa H. |
8 |
Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. Cai Q, Verma SC, Kumar P, Ma M, Robertson E.S. |
9 |
Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients. Simbiri KO, Murakami M, Feldman M, Steenhoff AP, Nkomazana O, Bisson G, Robertson E.S. |
10 |
Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. He Z., Liu Y., Liang D., Wang Z., Robertson E.S., Lan K. |